Literature DB >> 29198616

Incidence of hypoglycemia in newborns at risk and an audit of the 2011 American academy of pediatrics guideline for hypoglycemia.

Nihan Hilal Hosagasi1, Mustafa Aydin2, Aysegul Zenciroglu3, Nuran Ustun4, Serdar Beken5.   

Abstract

BACKGROUND: Hypoglycemia is low blood glucose level that may negatively affect neurological and developmental prognosis. The American Academy of Pediatrics (AAP), Committee on Fetus and Newborn defined the safe glucose concentrations in the 2011 guideline for newborns at risk for hypoglycemia. This study aimed to investigate the incidence and associated risk factors for hypoglycemia in newborn infants having risk and to assess compliance with the AAP guideline.
METHODS: According to 2011 AAP guideline for hypoglycemia, the newborns at risk for hypoglycemia included in this study were divided to four groups [infant of diabetic mother (IDM), large-for-gestational-age (LGA) infants, small-for-gestational-age (SGA) infants, and late preterm infants (LPI)].
RESULTS: Of the 207 newborn infants, there were 12 cases in IDM group (5.7%), 79 cases in LGA group (38.1%), 66 cases in SGA group (31.8%) and 50 cases in LPI group (24.1%). The incidences of hypoglycemia in these four groups were 2 (16.6%), 10 (12.7%), 8 (12.2%) and 17 (34%), respectively. Although the gender, delivery method, birth weight and 5-min Apgar score at 5-min were not found to be associated with hypoglycemia (P > 0.05), lower gestational age was determined to be associated with higher incidence of hypoglycemia (P = 0.02). Median first feeding time was 55 min and time between first nutrition and blood glucose measurement was 30 min in all cases.
CONCLUSION: Highest risk for hypoglycemia in early postnatal period was present especially in LPI group. Our compliance levels with the AAP guideline was found to be satisfactory.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  American academy of pediatrics guideline; Blood glucose checking; Breastfeeding; Incidence; Neonatal hypoglycemia; Newborn; Risk factors

Mesh:

Year:  2017        PMID: 29198616     DOI: 10.1016/j.pedneo.2017.11.009

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  6 in total

1.  [Glucose Variations in the First Day of Life of Newborns under Observational Surveillance].

Authors:  Jung Ae Cho; Kyoung Hee Son; Hyun Young Eom; Seo Hae Lim; Yong Hoon Jun; Young Mee Ahn
Journal:  Child Health Nurs Res       Date:  2020-04-30

2.  Neonatal hypoglycaemia and body proportionality in small for gestational age newborns: a retrospective cohort study.

Authors:  Ilke Smits; Liset Hoftiezer; Jeroen van Dillen; Marije Hogeveen
Journal:  Eur J Pediatr       Date:  2022-08-18       Impact factor: 3.860

3.  Neonatal hypoglycemia and the CPT1A P479L variant in term newborns: A retrospective cohort study of Inuit newborns from Kivalliq Nunavut.

Authors:  Sorcha A Collins; Gertrude Elizabeth Hildes-Ripstein; James Robert Thompson; Sharon Edmunds; Amber Miners; Cheryl Rockman-Greenberg; Laura Arbour
Journal:  Paediatr Child Health       Date:  2020-04-03       Impact factor: 2.253

4.  Risk Factor Assessment and the Incidence of Neonatal Hypoglycemia in the Postnatal Period.

Authors:  Ali Bülbül; Semra Bahar; Sinan Uslu; Şehrinaz Sözeri; Lida Bülbül; Evrim Kıray Baş; Ebru Türkoğlu Ünal
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2019-11-28

5.  Etiologic Classification of 541 Infantile Spasms Cases: A Cohort Study.

Authors:  Pan Peng; Miriam Kessi; Leilei Mao; Fang He; Ciliu Zhang; Chen Chen; Nan Pang; Fei Yin; Zou Pan; Jing Peng
Journal:  Front Pediatr       Date:  2022-03-07       Impact factor: 3.418

6.  Ultrasound prediction of adverse perinatal outcome at diagnosis of late-onset fetal growth restriction.

Authors:  A Dall'Asta; T Stampalija; F Mecacci; M Minopoli; G B L Schera; G Cagninelli; C Ottaviani; I Fantasia; M Barbieri; F Lisi; S Simeone; T Ghi; T Frusca
Journal:  Ultrasound Obstet Gynecol       Date:  2022-03       Impact factor: 8.678

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.